 Frances Feng
Concepts (45)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papanicolaou Test | 1 | 2024 | 35 | 0.860 |
Why?
| | Papillomaviridae | 1 | 2024 | 115 | 0.820 |
Why?
| | Histiocytosis, Sinus | 1 | 2022 | 7 | 0.750 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2024 | 269 | 0.680 |
Why?
| | Papillomavirus Infections | 1 | 2024 | 345 | 0.630 |
Why?
| | Genotype | 1 | 2024 | 1835 | 0.600 |
Why?
| | Early Detection of Cancer | 1 | 2024 | 466 | 0.600 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1322 | 0.380 |
Why?
| | Dendrimers | 1 | 2025 | 20 | 0.230 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2024 | 37 | 0.220 |
Why?
| | Squamous Intraepithelial Lesions of the Cervix | 1 | 2024 | 2 | 0.220 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2024 | 27 | 0.220 |
Why?
| | Vaginal Smears | 1 | 2024 | 55 | 0.210 |
Why?
| | Drug Carriers | 1 | 2025 | 130 | 0.210 |
Why?
| | Nanostructures | 1 | 2025 | 117 | 0.210 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 331 | 0.190 |
Why?
| | DNA, Viral | 1 | 2024 | 358 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 239 | 0.180 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2025 | 259 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1129 | 0.140 |
Why?
| | Diagnosis, Differential | 1 | 2022 | 1495 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1524 | 0.130 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4569 | 0.100 |
Why?
| | Aged | 2 | 2024 | 25947 | 0.100 |
Why?
| | Middle Aged | 2 | 2024 | 35928 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3869 | 0.080 |
Why?
| | Female | 4 | 2025 | 78376 | 0.070 |
Why?
| | Young Adult | 1 | 2024 | 14126 | 0.070 |
Why?
| | Retrospective Studies | 1 | 2024 | 17101 | 0.060 |
Why?
| | Drug Liberation | 1 | 2025 | 36 | 0.060 |
Why?
| | Chitosan | 1 | 2025 | 38 | 0.060 |
Why?
| | Methotrexate | 1 | 2025 | 240 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2025 | 221 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2024 | 264 | 0.050 |
Why?
| | Humans | 3 | 2025 | 144957 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2024 | 389 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2024 | 784 | 0.040 |
Why?
| | Adult | 1 | 2024 | 40506 | 0.040 |
Why?
| | Hydrogels | 1 | 2025 | 700 | 0.030 |
Why?
| | Mice | 2 | 2025 | 18365 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3550 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1496 | 0.030 |
Why?
| | Male | 1 | 2022 | 72406 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2025 | 2197 | 0.030 |
Why?
| | Animals | 2 | 2025 | 38109 | 0.020 |
Why?
|
|
Feng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|